These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32984001)

  • 1. CD47 Enhances Cell Viability and Migration Ability but Inhibits Apoptosis in Endometrial Carcinoma Cells via the PI3K/Akt/mTOR Signaling Pathway.
    Liu Y; Chang Y; He X; Cai Y; Jiang H; Jia R; Leng J
    Front Oncol; 2020; 10():1525. PubMed ID: 32984001
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of signal transduction inhibitors on human endometrial carcinoma cells with differential PTEN gene expression].
    Xiao L; Yang YB; Shen HM; Xu CF; Wang XY; Li XM
    Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):681-5. PubMed ID: 20079181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of mammalian target of rapamycin in Ishikawa and HEC-1A cells.
    Li X; Xiao L; Yang Y; Shen H; Zeng H; Wang Z
    J Huazhong Univ Sci Technolog Med Sci; 2008 Jun; 28(3):340-2. PubMed ID: 18563337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC01170 promotes the progression of endometrial carcinoma by activating the AKT pathway.
    Zhang Z; Liu X; Xu H; Li P; Zeng T; Du W; Lu X
    J BUON; 2018; 23(6):1745-1752. PubMed ID: 30610803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Apolipoprotein E enhances migration of endometrial cancer cells byactivating the ERK/MMP9 signaling pathway].
    Wu C; Cheng W
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Feb; 43(2):232-241. PubMed ID: 36946043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of CLDN6 inhibits cell proliferation and migration via PI3K/AKT/mTOR signaling pathway in endometrial carcinoma cell line HEC-1-B.
    Cao X; He GZ
    Onco Targets Ther; 2018; 11():6351-6360. PubMed ID: 30319275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian target of rapamycin inhibitor RAD001 sensitizes endometrial cancer cells to paclitaxel-induced apoptosis via the induction of autophagy.
    Wang H; Li D; Li X; Ou X; Liu S; Zhang Y; Ding J; Xie B
    Oncol Lett; 2016 Dec; 12(6):5029-5035. PubMed ID: 28105210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression and role of hybrid insulin/insulin-like growth factor receptor type 1 in endometrial carcinoma cells.
    Zhang G; Li X; Zhang L; Zhao L; Jiang J; Wang J; Wei L
    Cancer Genet Cytogenet; 2010 Jul; 200(2):140-8. PubMed ID: 20620597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Expression of the S100A8 Gene Encoding the S100 Calcium-Binding Protein A8 Promotes Apoptosis by Suppressing the Phosphorylation of Protein Kinase B (Akt) in Endometrial Carcinoma and HEC-1A Cells.
    Liu C; Xing G; Wu C; Zhu J; Wei M; Liu D; Ge Y; Chen Y; Lei T; Yang Y
    Med Sci Monit; 2018 Mar; 24():1836-1846. PubMed ID: 29595187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA DLEU1 contributes to tumorigenesis and development of endometrial carcinoma by targeting mTOR.
    Du Y; Wang L; Chen S; Liu Y; Zhao Y
    Mol Carcinog; 2018 Sep; 57(9):1191-1200. PubMed ID: 29745433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.
    Zhuo Z; Yu H
    Oncotarget; 2017 Apr; 8(17):28042-28051. PubMed ID: 28427207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin regulates cell autophagy in endometrial cancer cells via the PI3K/AKT/mTOR signalling pathway.
    Lin Q; Wang Y; Chen D; Sheng X; Liu J; Xiong H
    Oncol Lett; 2017 May; 13(5):3567-3571. PubMed ID: 28521459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation.
    Engel JB; Honig A; Schönhals T; Weidler C; Häusler S; Krockenberger M; Grunewald TG; Dombrowski Y; Rieger L; Dietl J; Wischhusen J
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):64-9. PubMed ID: 18687514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of pertussis toxin on GPER-mediated activation of phosphatidylinositol 3-kinase/protein kinase B signaling induced by 17β-estradiol in endometrial carcinoma cells].
    Guo RX; Lei J; Wang XY; Ge X; Hu DM; Ma XY; Li LX; Qiao YH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):129-33. PubMed ID: 23544495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of endometrial carcinoma by Kaempferol is interceded through apoptosis induction, G2/M phase cell cycle arrest, suppression of cell invasion and upregulation of m-TOR/PI3K signalling pathway.
    Lei X; Guo J; Wang Y; Cui J; Feng B; Su Y; Zhao H; Yang W; Hu Y
    J BUON; 2019; 24(4):1555-1561. PubMed ID: 31646808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Overexpression of estrogen receptor-related receptor alpha can stimulate estrogen receptor negative endometrial cancer cell proliferation].
    Sun PM; Wei LH; Gao M; Wang JL; Zhao LJ; Wang DP; Zhang JX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):408-11. PubMed ID: 17697604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRIG2 is a growth suppressor of Hec-1A and Ishikawa endometrial adenocarcinoma cells by regulating PI3K/AKT- and EGFR-mediated apoptosis and cell-cycle.
    Suh DS; Park SE; Jin H; Lee K; Bae J
    Oncogenesis; 2018 Jan; 7(1):3. PubMed ID: 29358688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An estrogen receptor alpha-dependent regulation of estrogen receptor-related receptor alpha in the proliferation of endometrial carcinoma cells.
    Sun PM; Gao M; Wei LH; Mustea A; Wang JL; Könsgen D; Lichtenegger W; Sehouli J
    Int J Gynecol Cancer; 2006; 16 Suppl 2():564-8. PubMed ID: 17010074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
    Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
    Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of lncRNA TDRG1 Inhibits Tumorigenesis in Endometrial Carcinoma Through the PI3K/AKT/mTOR Pathway.
    Sun R; Sun X; Liu H; Li P
    Onco Targets Ther; 2019; 12():10863-10872. PubMed ID: 31849490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.